Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Companies can leverage local partnerships with distributors, hospitals, and government health programs to expand access
Chronic non-communicable diseases (NCDs), including cardiovascular disease, Type 2 diabetes, obesity, metabolic syndrome, and metabolic-associated fatty liver disease, continue to rise worldwide 1
World Health Organization estimates show that in 2022 1 in 8 people in the world had obesity, which doubled compared to data from 1990
Middle East GLP-1 Receptor Agonist Market Overview by Country Segment 17.1.1
never take these medicines without a medical prescription or supervision
US$ 20.71
US$ 26.81
US$ 24.55
US$ 21.93
US$ 23.70
US$ 29.79
US$ 21.50
